| Single-kidney transplantation with discarded partner kidney vs. Dual kidney transplantation : results from a national cohort study | BMC nephrology |  | | 2026 | 18 | 28 |
|
| Preformed donor-specific antibodies are associated with acute rejection and biliary complications after liver transplantation : A Swiss Transplant Cohort Study analysis | Liver transplantation | | | 2026 | 22 | 93 |
|
| Influence of the shared epitope on the effectiveness of biologic antirheumatic agents in European patients with rheumatoid arthritis | RMD open | | | 2026 | 9 | 24 |
|
| Integrating killer cell immunoglobulin-like receptor high-resolution genotyping for predicting transplant outcomes in allogeneic hematopoietic stem cell transplantation | Haematologica | | | 2026 | 15 | 36 |
|
| Assessment of access and outcomes of kidney transplantation through the reforms of the Swiss organ allocation system | Frontiers in public health | | | 2025 | 128 | 252 |
|
| Engineered CD4 TCR T cells with conserved high-affinity TCRs targeting NY-ESO-1 for advanced cellular therapies in cancer | Science advances | | | 2025 | 106 | 271 |
|
| Incidence and Risk Factors for Infection in Heart Transplant Recipients on Posttransplant Extracorporeal Membrane Oxygenation (ECMO) | Transplantation direct | | | 2025 | 27 | 138 |
|
| Comparing variable and feature selection strategies for prediction - protocol of a simulation study in low-dimensional transplantation data | PloS one | | | 2025 | 29 | 230 |
|
| Reintegration Into the Workforce After Kidney Transplantation Based on Urbanization Status in Switzerland | Kidney international reports | | | 2025 | 117 | 230 |
|
| Influence of time-of-day of graft infusion on allogeneic hematopoietic stem cell transplantation outcomes : a validation cohort study | Journal for immunotherapy of cancer | | | 2025 | 11 | 54 |
|
| Enhancing post-kidney transplant prognostication: an interpretable machine learning approach for longitudinal outcome prediction | npj digital medicine | | | 2025 | 14 | 39 |
|
| Outcome of Patients Transplanted for C3 Glomerulopathy and Primary Immune Complex-Mediated Membranoproliferative Glomerulonephritis | Kidney international reports | | | 2025 | 60 | 500 |
|
| Invasive Candida infections in solid organ transplant recipients between 2008 and 2020 | American Journal of Transplantation | | | 2025 | 36 | 207 |
|
| Surgical site infections, risk factors, and outcomes after liver transplant | JAMA network open | | | 2025 | 84 | 259 |
|
| Overall survival of recurrent/metastatic head & neck squamous cell carcinoma patients progressing after ≥ 1 line of systemic therapy, treated with MVX-ONCO-1, a novel, first in class cell encapsulation-based immunotherapy : results of SAKK 11/16, a phase IIa trial | Experimental hematology & oncology | | | 2025 | 72 | 117 |
|
| A First-in-Human Phase I Clinical Study with MVX-ONCO-1, a Personalized Active Immunotherapy, in Patients with Advanced Solid Tumors | Cancer research communications | | | 2024 | 121 | 260 |
|
| Infectious disease events in people with HIV receiving kidney transplantation : Analysis of the Swiss HIV Cohort Study and the Swiss Transplant Cohort Study | BMC infectious diseases | | | 2024 | 76 | 170 |
|
| Do infectious diseases after kidney retransplantation differ from those after first kidney transplantation ? | Open forum infectious diseases | | | 2024 | 122 | 168 |
|
| Pitfalls in Valganciclovir Prophylaxis Dose Adjustment Based on Renal Function in Kidney Transplant Recipients | Transplant international | | | 2024 | 120 | 243 |
|
| BK polyomavirus serotype-specific antibody responses in blood donors and kidney transplant recipients with and without new-onset BK polyomavirus-DNAemia : A Swiss Transplant Cohort Study | American journal of transplantation | | | 2024 | 61 | 130 |
|
| Antibody and T-cell response to bivalent booster SARS-CoV-2 vaccines in people with compromised immune function (COVERALL-3) | The Journal of infectious diseases | | | 2024 | 531 | 712 |
|
| Surgical site infections after kidney transplantation are independently associated with graft loss | American journal of transplantation | | | 2024 | 73 | 312 |
|
| Frequency and impact on renal transplant outcomes of urinary tract infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species | Frontiers in medicine | | | 2024 | 97 | 106 |
|
| Epidemiology, outcomes and risk factors for recurrence of Clostridioides difficile infections following allogeneic hematopoietic cell transplantation : a longitudinal retrospective multicenter study | Bone marrow transplantation | | | 2024 | 92 | 142 |
|
| NK and T cell repertoire is established early after allogeneic HSCT and is profoundly imprinted by CMV reactivation | Blood advances | | | 2024 | 128 | 154 |
|
| Néphrologie solidaire : la coopération Genève-Yaoundé | Revue médicale suisse | | | 2023 | 95 | 561 |
|
| Vaccine-preventable infections among solid organ transplant recipients in Switzerland | JAMA network open | | | 2023 | 148 | 213 |
|
| Donor-derived fulminant herpes simplex virus hepatitis after liver transplantation : Two cases and review of literature | Transplant infectious disease | | | 2023 | 144 | 241 |
|
| Donation type and the effect of pre-transplant donor specific antibodies - Data from the Swiss Transplant Cohort Study | Frontiers in immunology | | | 2023 | 169 | 75 |
|
| CMV serostatus and T-cell repertoire diversity 5 years after allogeneic hematopoietic stem cell transplantation | Leukemia & lymphoma | | | 2023 | 90 | 141 |
|
| Immunogenicity of High-Dose vs. MF59-adjuvanted vs. Standard Influenza Vaccine in Solid Organ Transplant Recipients : The STOP-FLU trial | Clinical infectious diseases | | | 2023 | 115 | 262 |
|
| Clinical prediction model for prognosis in kidney transplant recipients (KIDMO) : study protocol | Diagnostic and prognostic research | | | 2023 | 90 | 298 |
|
| An automated histological classification system for precision diagnostics of kidney allografts | Nature medicine |  | | 2023 | 110 | 0 |
|
| Immune monitoring-guided vs fixed duration of antiviral prophylaxis against cytomegalovirus in solid-organ transplant recipients. A Multicenter, Randomized Clinical Trial | Clinical infectious diseases | | | 2023 | 157 | 343 |
|
| Antibody Response After the Third SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients and People Living With HIV (COVERALL-2) | Open forum infectious diseases | | | 2023 | 103 | 132 |
|
| Bacteremia During the First Year After Solid Organ Transplantation : An Epidemiological Update | Open forum infectious diseases | | | 2023 | 135 | 154 |
|
| Matching for HLA-DR excluding diabetogenic HLA-DR3 and HLA-DR4 predicts insulin independence after pancreatic islet transplantation | Frontiers in immunology | | | 2023 | 91 | 96 |
|
| Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2 : Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2) | Open forum infectious diseases | | | 2023 | 155 | 156 |
|
| HLA variants and TCR diversity against SARS-CoV-2 in the pre-COVID-19 era | HLA | | | 2023 | 116 | 119 |
|
| The impact of pre-transplant donor specific antibodies on the outcome of kidney transplantation – Data from the Swiss transplant cohort study | Frontiers in immunology | | | 2022 | 204 | 132 |
|
| Personalized immunotherapy with encapsulated cell technology : Feasibility, safety and efficacy results from the first-in-human clinical trial in advanced relapsing solid tumors | ESMO Congress 2022 | | | 2022 | 101 | 236 |
|
| Analysis of T cell Repertoire and Transcriptome Identifies Mechanisms of Regulatory T cell (Treg) Suppression of GvHD | Blood | | | 2022 | 516 | 210 |
|
| Regulation of HLA class I expression by non-coding gene variations | PLOS genetics | | | 2022 | 183 | 481 |
|
| A National Survey Comparing Patients' and Transplant Professionals' Research Priorities in the Swiss Transplant Cohort Study | Transplant international | | | 2022 | 223 | 155 |
|
| Atopy as an independent predictor for long-term patient and graft survival after kidney transplantation | Frontiers in rheumatology & clinical immunology | | | 2022 | 185 | 51 |
|
| Use of statins after liver transplantation is associated with improved survival: results of a nationwide study | Alimentary pharmacology & therapeutics | | | 2022 | 163 | 337 |
|
| Antibody‐mediated rejection after kidney transplantation in children; therapy challenges and future potential treatments | Clinical transplantation | | | 2022 | 143 | 2,086 |
|
| Epidemiology and outcomes of bone and joint infections in solid organ transplant recipients | American journal of transplantation | | | 2022 | 255 | 161 |
|
| Fitness of B-Cell Responses to SARS-CoV-2 WT and Variants Up to One Year After Mild COVID-19 – A Comprehensive Analysis | Frontiers in immunology | | | 2022 | 210 | 237 |
|
| Analysis of biological models to predict clinical outcomes based on HLA-DPB1 disparities in unrelated transplantation | Blood advances | | | 2021 | 330 | 170 |
|
| Infectious complications and graft outcome following treatment of acute antibody-mediated rejection after kidney transplantation: A nationwide cohort study | PLOS ONE | | | 2021 | 335 | 496 |
|
| Temporal trends, risk factors and outcomes of infections due to extended-spectrum β-lactamase producing Enterobacterales in Swiss solid organ transplant recipients between 2012 and 2018 | Antimicrobial resistance and infection control | | | 2021 | 396 | 194 |
|
| Clinical considerations on posaconazole administration and therapeutic drug monitoring in allogeneic hematopoietic cell transplant recipients | Medical mycology | | | 2021 | 374 | 1 |
|
| Genetic T-cell receptor diversity at 1 year following allogeneic hematopoietic stem cell transplantation | Leukemia | | | 2020 | 415 | 378 |
|
| Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination | NPJ Vaccines | | | 2020 | 488 | 154 |
|
| CD8+ T-Cell Repertoire in Human Leukocyte Antigen Class I-Mismatched Alloreactive Immune Response | Frontiers in Immunology | | | 2020 | 251 | 265 |
|
| Immunologic clearance of a BK virus-associated metastatic renal allograft carcinoma | Transplantation | | | 2020 | 356 | 531 |
|
| Preformed and de novo DSA are associated with T-cell-mediated rejection in pediatric liver transplant recipients requiring clinically indicated liver biopsy | Pediatric Transplantation | | | 2020 | 419 | 2 |
|
| HLA-B leader and survivorship after HLA-mismatched unrelated donor transplantation | Blood | | | 2020 | 371 | 0 |
|
| Role of HLA-DP Expression in Graft-Versus-Host Disease After Unrelated Donor Transplantation | Journal of Clinical Oncology | | | 2020 | 198 | 0 |
|
| Burden and Timeline of Infectious Diseases in the First Year After Solid Organ Transplantation in the Swiss Transplant Cohort Study | Clinical Infectious Diseases | | | 2020 | 355 | 317 |
|
| Impact of donor KIRs and recipient KIR/HLA class I combinations on GVHD in patients with acute leukemia after HLA-matched sibling HSCT | Human Immunology | | | 2020 | 208 | 13 |
|
| Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort study | The Lancet. Haematology | | | 2020 | 284 | 0 |
|
| Peripheral donor specific antibodies are associated with histology and cellular subtypes in protocol liver biopsies of pediatric recipients | Transplantation | | | 2020 | 380 | 268 |
|
| Natural Killer Cell Alloreactivity Against Human Induced Pluripotent Stem Cells and Their Neuronal Derivatives into Dopaminergic Neurons | Stem Cells and Development |  | | 2020 | 321 | 1 |
|
| Detection of circulating highly expanded T-cell clones in at-risk individuals for rheumatoid arthritis before the clinical onset of the disease | Rheumatology | | | 2020 | 340 | 9 |
|
| Vitamin d status and risk of infections after liver transplantation in the swiss transplant cohort study | Transplant International | | | 2019 | 561 | 0 |
|
| Management of allergy transfer upon solid organ transplantation | American Journal of Transplantation | | | 2019 | 404 | 320 |
|
| High-resolution HLA phased haplotype frequencies to predict the success of unrelated donor searches and clinical outcome following hematopoietic stem cell transplantation | Bone Marrow Transplantation | | | 2019 | 466 | 181 |
|
| Epidemiology, risk factors and outcomes of invasive aspergillosis in solid organ transplant recipients in the Swiss Transplant Cohort Study | Transplant Infectious Disease | | | 2018 | 600 | 0 |
|
| Endothelial chimerism and vascular sequestration protect pancreatic islet grafts from antibody-mediated rejection | Journal of Clinical Investigation | | | 2018 | 481 | 308 |
|
| Identification of seven novel HLA class I and II alleles | HLA | | | 2018 | 261 | 0 |
|
| Clinical and histological evolution after de novo donor-specific anti-human leukocyte antigen antibodies: a single centre retrospective study | BMC Nephrology | | | 2018 | 562 | 233 |
|
| LILRB1 polymorphisms influence posttransplant HCMV susceptibility and ligand interactions | Journal of Clinical Investigation | | | 2018 | 491 | 273 |
|
| Factors associated with immune hemolytic anemia after pediatric liver transplantation | Pediatric Transplantation | | | 2018 | 393 | 1 |
|
| Cost-effectiveness of HLA-DQB1/HLA-B pharmacogenetic-guided treatment and blood monitoring in US patients taking clozapine | The Pharmacogenomics Journal | | | 2018 | 670 | 419 |
|
| A Systematic Review and Meta-Analysis of HCV Clearance | Liver international | | | 2017 | 616 | 1 |
|
| The HLA-B landscape of Africa: Signatures of pathogen-driven selection and molecular identification of candidate alleles to malaria protection | Molecular Ecology | | | 2017 | 654 | 694 |
|
| Identification of 3 novel HLA-B alleles: B*08:173, B*18:72:03 and B*53:05:02 | HLA | | | 2017 | 569 | 0 |
|
| Immunogenicity of anti-HLA antibodies in pancreas and islet transplantation | Cell transplantation | | | 2016 | 566 | 3 |
|
| Human Cytomegalovirus Infection Enhances NK Cell Activity In Vitro | Transplantation direct | | | 2016 | 704 | 590 |
|
| A significant effect of the killer cell immunoglobulin-like receptor ligand human leucocyte antigen-C on fibrosis progression in chronic C hepatitis with or without liver transplantation | Liver international | | | 2016 | 575 | 1 |
|
| Identification of the novel HLA-B*07:261 allele | HLA | | | 2016 | 553 | 0 |
|
| Felty's syndrome and hypofibrinogenemia: an unusual target for anti-cyclic citrullinated peptide antibodies? | Modern rheumatology | | | 2015 | 701 | 0 |
|
| Kidney paired donation: a plea for a Swiss National Programme | Schweizerische medizinische Wochenschrift | | | 2015 | 731 | 538 |
|
| Atypical Hemolytic Uremic Syndrome Recurrence after Renal Transplantation: C3-Glomerulonephritis as an Initial Presentation | Transplantation direct | | | 2015 | 524 | 2 |
|
| Restoration of hematopoiesis in a case of myelodysplastic syndrome associated with systemic lupus erythematosus treated with rituximab | Annals of hematology | | | 2015 | 622 | 2 |
|
| Long-term follow-up of cadaveric breast augmentation: what can we learn? | Aesthetic surgery journal | | | 2015 | 648 | 2 |
|
| Very Long Term Stability of Mixed Chimerism after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematologic Malignancies | Bone marrow research | | | 2015 | 599 | 253 |
|
| Protection From Varicella Zoster in Solid Organ Transplant Recipients Carrying Killer Cell Immunoglobulin-Like Receptor B Haplotypes | Transplantation | | | 2015 | 553 | 0 |
|
| Potential and limitation of HLA-based banking of human pluripotent stem cells for cell therapy | Journal of immunology research | | | 2014 | 525 | 0 |
|
| Prédispositions génétiques dans l'allergie médicamenteuse : importance du HLA | Revue médicale suisse | | | 2014 | 533 | 0 |
|
| KIR-associated protection from CMV replication requires pre-existing immunity: a prospective study in solid organ transplant recipients | Genes and immunity | | | 2014 | 690 | 0 |
|
| Expression of killer cell immunoglobulin-like receptors (KIRs) by natural killer cells during acute CMV infection after kidney transplantation | Transplant immunology | | | 2014 | 707 | 2 |
|
| Interaction of ES cell derived neural progenitor cells with natural killer cells and cytotoxic T cells | Methods in molecular biology | | | 2013 | 679 | 2 |
|
| The clinical relevance of pre-formed anti-HLA and anti-MICA antibodies after cord blood transplantation in children | PloS one | | | 2013 | 741 | 450 |
|
| Transplanted human pancreatic islets after long-term insulin independence | American journal of transplantation | | | 2013 | 880 | 1 |
|
| The role of immunosuppression in the transplantation of allogenic neural precursors derived from human pluripotent stem cells for Parkinson's disease | Stem cell research & therapy | | | 2013 | 1,011 | 387 |
|
| Pretransplant HLA mistyping in diagnostic samples of acute myeloid leukemia patients due to acquired uniparental disomy | Leukemia | | | 2012 | 1,282 | 881 |
|
| HLA and non-HLA polymorphisms in renal transplantation | Schweizerische medizinische Wochenschrift | | | 2012 | 675 | 1 |
|
| Third-party mesenchymal stromal cell infusion is associated with a decrease in thrombotic microangiopathy symptoms observed post-hematopoietic stem cell transplantation | Pediatric transplantation | | | 2012 | 743 | 0 |
|
| Haplotype-based banking of human pluripotent stem cells for transplantation: potential and limitations | Stem cells and development | | | 2012 | 705 | 990 |
|
| Posttransplant cellular immune reactivity against donor antigen correlates with clinical islet transplantation outcome: towards a better posttransplant monitoring | Cell transplantation | | | 2012 | 626 | 0 |
|
| Strong serological responses and HIV RNA increase following AS03-adjuvanted pandemic immunization in HIV-infected patients | HIV medicine | | | 2012 | 737 | 0 |
|
| Detection of anti-HLA antibodies by solid-phase assay in kidney transplantation: friend or foe? | Tissue antigens | | | 2012 | 716 | 0 |
|
| Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients | Haematologica | | | 2011 | 1,067 | 704 |
|
| Monitoring of CD4+CD25highIL-7Rαhigh activated T cells in kidney transplant recipients | Clinical journal of the American Society of Nephrology | | | 2011 | 628 | 0 |
|
| Introduction: Immunopathology and the promise of stem cell research | Seminars in immunopathology | | | 2011 | 659 | 151 |
|
| Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study | Arthritis and rheumatism | | | 2011 | 895 | 8 |
|
| Eculizumab in acute recurrence of thrombotic microangiopathy after renal transplantation | American journal of transplantation | | | 2011 | 761 | 0 |
|
| Human bone marrow stromal cells and skin fibroblasts inhibit natural killer cell proliferation and cytotoxic activity | Cell transplantation | | | 2011 | 712 | 0 |
|
| De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipients | American journal of transplantation | | | 2011 | 677 | 0 |
|
| How to cross immunogenetic hurdles to human embryonic stem cell transplantation | Seminars in immunopathology | | | 2011 | 645 | 424 |
|
| The role of natural killer cells in human solid organ and tissue transplantation | Journal of innate immunity | | | 2011 | 594 | 0 |
|
| Donor-specific antibody levels and three generations of crossmatches to predict antibody-mediated rejection in kidney transplantation | Transplantation | | | 2010 | 670 | 0 |
|
| Early relapse of autoimmune glomerulonephritis after kidney transplantation despite antibody induction and triple-drug-based immunosuppression | Transplantation | | | 2010 | 666 | 0 |
|
| Natural killer cell receptor--repertoire and functions after induction therapy by polyclonal rabbit anti-thymocyte globulin in unsensitized kidney transplant recipients | Clinical immunology | | | 2010 | 661 | 0 |
|
| The transcription factor RFX protects MHC class II genes against epigenetic silencing by DNA methylation | The Journal of immunology | | | 2009 | 727 | 0 |
|
| Neural progenitors derived from human embryonic stem cells are targeted by allogeneic T and natural killer cells | Journal of Cellular and Molecular Medicine | | | 2009 | 621 | 197 |
|
| Humoral and cellular rejection after combined liver-kidney transplantation in low immunologic risk recipients | Transplant international | | | 2009 | 658 | 0 |
|
| Long-term insulin-independence after allogeneic islet transplantation for type 1 diabetes: over the 10-year mark | American journal of transplantation | | | 2009 | 991 | 6 |
|
| Sequence of a novel HLA-A2 allele in a haematopoietic stem cell donor of the international registry | Tissue antigens | | | 2009 | 645 | 0 |
|
| Pluripotent stem cells as new drugs? The example of Parkinson's disease | International journal of pharmaceutics | | | 2009 | 793 | 3 |
|
| A new HLA-DR4 allele, DRB1*0474, with an unusual residue at position 77 | Tissue antigens | | | 2008 | 652 | 1 |
|
| Low risk of anti-human leukocyte antigen antibody sensitization after combined kidney and islet transplantation | Transplantation | | | 2008 | 937 | 0 |
|
| Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation | American journal of transplantation | | | 2008 | 787 | 0 |
|
| IL-21 promotes survival and maintains a naive phenotype in human CD4+ T lymphocytes | International immunology | | | 2008 | 588 | 164 |
|
| DNA typing by microbead arrays and PCR-SSP: apparent false-negative or -positive hybridization or amplification signals disclose new HLA-B and -DRB1 alleles | Tissue antigens | | | 2008 | 597 | 0 |
|
| Human herpesvirus-6 variant A encephalomyelitis | Neurology | | | 2008 | 687 | 0 |
|
| The proinflammatory cytokines IL-2, IL-15 and IL-21 modulate the repertoire of mature human natural killer cell receptors | Arthritis Research and Therapy | | | 2007 | 251 | 314 |
|
| Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab | Transplant international | | | 2007 | 864 | 0 |
|
| Regulatory T-cell recovery in recipients of haploidentical nonmyeloablative hematopoietic cell transplantation with a humanized anti-CD2 mAb, MEDI-507, with or without fludarabine | Experimental Hematology | | | 2007 | 209 | 0 |
|
| Molecular mechanism of flucytosine resistance in Candida lusitaniae: contribution of the FCY2, FCY1, and FUR1 genes to 5-fluorouracil and fluconazole cross-resistance | Antimicrobial Agents and Chemotherapy | | | 2007 | 278 | 0 |
|
| Investigation of alloreactive NK cells in mixed lymphocyte reactions using paraformaldehyde-silenced target cells | Journal of Immunological Methods | | | 2007 | 210 | 0 |
|
| Pretransplantation CMV-specific T cells protect recipients of T-cell-depleted grafts against CMV-related complications | Blood | | | 2006 | 650 | 0 |
|
| Anti-HLA antibody repertoire after IVIg infusion in highly sensitized patients waiting for kidney transplantation | Schweizerische medizinische Wochenschrift | | | 2006 | 540 | 451 |
|
| Acute humoral rejection in kidney allograft following a third-party arterial transplantation | American journal of transplantation | | | 2006 | 644 | 0 |
|
| Differentiation between atypical isolates of Candida lusitaniae and Candida pulcherrima by determination of mating type | Journal of Clinical Microbiology | | | 2005 | 226 | 0 |
|
| Microchimerism after liver transplantation: absence of rejection without abrogation of anti-donor cytotoxic T-lymphocyte-mediated alloreactivity | Liver transplantation | | | 2005 | 557 | 549 |
|
| Pseudovasculitis and corticosteroid therapy | Clinical rheumatology | | | 2005 | 591 | 285 |
|
| Inactivation of the FCY2 gene encoding purine-cytosine permease promotes cross-resistance to flucytosine and fluconazole in Candida lusitaniae | Antimicrobial Agents and Chemotherapy | | | 2005 | 212 | 229 |
|
| Development of an integrative transformation system for the opportunistic pathogenic yeast Candida lusitaniae using URA3 as a selection marker | Yeast | | | 2004 | 186 | 0 |
|
| Cellular and Gene Therapy for Major Histocompatibility Complex Class II Deficiency | News in physiological sciences | | | 2004 | 117 | 0 |
|
| A new DR7-DQ8 haplotype resulting from a recombination between the DQA1 and DQB1 loci in a leukemic patient of Caucasoid origin | Immunogenetics | | | 2004 | 263 | 0 |
|
| Activating CD94:NKG2C and inhibitory CD94:NKG2A receptors are expressed by distinct subsets of committed CD8+ TCR alphabeta lymphocytes | European Journal of Immunology | | | 2004 | 279 | 344 |
|
| Monoclonal T-cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating CD94:NKG2C/E and NKD2D killer cell receptors | Blood | | | 2003 | 317 | 382 |
|
| Flucytosine-fluconazole cross-resistance in purine-cytosine permease-deficient Candida lusitaniae clinical isolates: indirect evidence of a fluconazole uptake transporter | Antimicrobial Agents and Chemotherapy | | | 2003 | 200 | 311 |
|
| Direct genetic correction as a new method for diagnosis and molecular characterization of MHC class II deficiency | Molecular therapy | | | 2002 | 657 | 0 |
|
| Selection of unrelated bone marrow donors by serology, molecular typing and cellular assays | Transplant Immunology | | | 2002 | 168 | 0 |
|
| Expression of the three human major histocompatibility complex class II isotypes exhibits a differential dependence on the transcription factor RFXAP | Molecular and cellular biology | | | 2001 | 542 | 0 |
|
| A functionally essential domain of RFX5 mediates activation of major histocompatibility complex class II promoters by promoting cooperative binding between RFX and NF-Y | Molecular and cellular biology | | | 2000 | 674 | 0 |
|
| Dissection of functional NF-Y-RFX cooperative interactions on the MHC class II Ea promoter | Journal of Molecular Biology | | | 2000 | 677 | 0 |
|
| Molecular genetics of the Bare lymphocyte syndrome | Reviews in immunogenetics | | | 2000 | 582 | 0 |
|
| Lessons from the bare lymphocyte syndrome: molecular mechanisms regulating MHC class II expression | Immunological reviews | | | 2000 | 679 | 0 |
|
| CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex | Genes & development | | | 2000 | 506 | 0 |
|
| The molecular basis of MHC class II deficiency and transcriptional control of MHC class II gene expression | Microbes and infection | | | 1999 | 608 | 0 |
|
| CIITA-induced occupation of MHC class II promoters is independent of the cooperative stabilization of the promoter-bound multi-protein complexes | International immunology | | | 1999 | 623 | 0 |
|
| Genetic and molecular definition of complementation group D in MHC class II deficiency | Human molecular genetics | | | 1998 | 644 | 0 |
|
| MHC class II deficiency: definition of a new complementation group | Immunobiology | | | 1997 | 634 | 0 |
|
| Analysis of mutations and chromosomal localisation of the gene encoding RFX5, a novel transcription factor affected in major histocompatibility complex class II deficiency | Human mutation | | | 1997 | 635 | 0 |
|
| Mutation of RFXAP, a regulator of MHC class II genes, in primary MHC class II deficiency | The New England journal of medicine | | | 1997 | 654 | 0 |
|
